Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
Appointed director
|
|
TriVascular Technologies, Inc. (TRIV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/08/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/17/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 02/16/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 02/05/2016 |
RW
| Form RW - Registration Withdrawal Request |
| 02/05/2016 |
RW
| Form RW - Registration Withdrawal Request |
| 02/04/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 02/03/2016 |
8-K
| Quarterly results |
| 01/25/2016 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 01/07/2016 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 11/09/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
| 11/09/2015 |
8-K
| Quarterly results |
| 10/26/2015 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits|
Docs:
|
"Agreement and Plan of Merger, among Endologix, Inc., TriVascular Technologies, Inc., and Teton Merger Sub Inc. Schedules to the Agreement and Plan of Merger have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant will furnish copies of any such schedules to the U.S. Securities and Exchange Commission upon request",
"Form of Voting Agreement, by and among Endologix, Inc., Teton Merger Sub Inc. and certain stockholders of TriVascular Technologies, Inc",
"Endologix, Inc. and TriVascular Technologies, Inc. Announce Merger to Create a Leading Cardiovascular Growth Company Focused on the Treatment of Aortic Disorders" |
|
| 10/26/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 08/05/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
| 08/04/2015 |
8-K
| Quarterly results |
| 08/04/2015 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Second Amended and Restated Term Loan Agreement, by and among TriVascular Technologies, Inc., TriVascular, Inc., TriVascular Sales LLC, TriVascular Canada, LLC and Capital Royalty Partners II L.P., Parallel Investment Opportunities Partners II L.P., Capital Royalty Partners II—Parallel Fund “A” L.P., Capital Royalty Partners II (Cayman) L.P. and Capital Royalty Partners II—Parallel Fund “B” (Cayman) L.P.",
"Form of Registration Rights Agreement, by and among TriVascular Technologies, Inc. and Capital Royalty Partners II L.P., Parallel Investment Opportunities Partners II L.P., Capital Royalty Partners II—Parallel Fund “A” L.P., Capital Royalty Partners II (Cayman) L.P. and Capital Royalty Partners II—Parallel Fund “B” (Cayman) L.P" |
|
| 05/29/2015 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 05/27/2015 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/06/2015 |
10-Q
| Quarterly Report for the period ended March 31, 2015 |
| 05/05/2015 |
8-K
| Quarterly results |
| 04/14/2015 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 04/08/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 03/09/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 03/04/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/03/2015 |
8-K
| Quarterly results |
| 01/12/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 11/12/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 11/10/2014 |
8-K
| Quarterly results |
| 11/10/2014 |
8-K
| Credit agreement amendment|
Docs:
|
"Amended and Restated Term Loan Agreement, by and among TriVascular Technologies, Inc., TriVascular, Inc., TriVascular Sales LLC and Capital Royalty Partners II L.P., Parallel Investment Opportunities Partners II L.P., Capital Royalty Partners II—Parallel Fund “A” L.P., Capital Royalty Partners II (Cayman) L.P. and Capital Royalty Partners II—Parallel Fund “B” (Cayman) L.P.",
"First Amendment to Loan Agreement, by and among TriVascular Technologies, Inc., TriVascular, Inc., TriVascular Sales LLC and Century Medical, Inc." |
|
| 09/18/2014 |
8-K
| Regulation FD Disclosure |
| 09/18/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
|
|
|